Drugs used by hospitals to intubate and treat patients with COVID-19 are in short supply; rapid tests will be sent to Native American, rural populations; data shows a rise in nonfatal drug overdoses between 2016 and 2017.
Some medicines used to alleviate breathing difficulty and sedate patients with coronavirus disease 2019 (COVID-19) are being depleted due to high demand, The New York Times reports. Medications including those used to keep individual’s airways open, antibiotics, antivirals, and sedatives, have been the most commonly reported shortages. According to the Times, the demand for fentanyl increased by 100% in March, along with sharp increases in other medicines for sedation and pain relief. While hospitals are bearing the brunt of the shortage, long-term care facilities, home care settings, and retail pharmacies have also reported shortages.The Indian Health Service and Americans living in rural parts of the country will have priority access to rapid COVID-19 tests, Politico reports. These populations were selected as they have limited access to testing and nursing homes, according to Deborah Birx, a White House coronavirus coordinator. The FDA recently authorized Abbott Laboratories’ point-of-care test that can return results in around 15 minutes. However, according to Kaiser Health News, only around 5500 of these tests will be distributed to state and local health labs.New CDC data shows that in addition to increases in fatal drug overdoses, rates of nonfatal overdoses have increased in recent years. Between 2016 and 2017 fatal drug overdoses increased by 10% in the United States. In that same time frame, the number of emergency department visits for nonfatal overdoses rose 4%. Specifically, nonfatal overdose rates increased by 3.1% for all opioids, 3.6% for non-heroin opioids, 3.6% for heroin and 32.9% for cocaine. The highest overdose rates for all drugs were among females and individuals in the Midwest.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More